<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fortis S</submitter><funding>NCATS NIH HHS</funding><funding>COPD Foundation</funding><funding>NIBIB NIH HHS</funding><funding>NIEHS NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>National Institutes of Health</funding><funding>CSRD VA</funding><pagination>94-103</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8295909</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>160(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Mild expiratory flow limitation may not be recognized using traditional spirometric criteria based on the ratio of FEV&lt;sub>1&lt;/sub>/FVC.&lt;h4>Research question&lt;/h4>Does slow vital capacity (SVC) instead of FVC increase the sensitivity of spirometry to identify patients with early or mild obstructive lung disease?&lt;h4>Study design and methods&lt;/h4>We included 854 current and former smokers from the Subpopulations and Intermediate Outcome Measures in COPD Study cohort with a postbronchodilator FEV&lt;sub>1&lt;/sub>/FVC ≥ 0.7 and FEV&lt;sub>1&lt;/sub> % predicted of ≥ 80% at enrollment. We compared baseline characteristics, chest CT scan features, exacerbations, and progression to COPD (postbronchodilator FEV&lt;sub>1&lt;/sub>/FVC, &lt; 0.7) during the follow-up period between 734 participants with </pubmed_abstract><journal>Chest</journal><pubmed_title>Ratio of FEV&lt;sub>1&lt;/sub>/Slow Vital Capacity of &lt; 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.</pubmed_title><pmcid>PMC8295909</pmcid><funding_grant_id>P30 ES005605</funding_grant_id><funding_grant_id>T32 HL007106</funding_grant_id><funding_grant_id>R01 HL151421</funding_grant_id><funding_grant_id>U01 HL137880</funding_grant_id><funding_grant_id>HHSN268200900015C</funding_grant_id><funding_grant_id>HHSN268200900016C</funding_grant_id><funding_grant_id>I01 CX000911</funding_grant_id><funding_grant_id>HHSN268200900017C</funding_grant_id><funding_grant_id>HHSN268200900018C</funding_grant_id><funding_grant_id>HHSN268200900019C</funding_grant_id><funding_grant_id>U24 HL141762</funding_grant_id><funding_grant_id>R01 HL122438</funding_grant_id><funding_grant_id>K24 HL138188</funding_grant_id><funding_grant_id>KL2 TR001882</funding_grant_id><funding_grant_id>HHSN268200900020C</funding_grant_id><funding_grant_id>HHSN268200900013C</funding_grant_id><funding_grant_id>TL1 TR001883</funding_grant_id><funding_grant_id>HHSN268200900014C</funding_grant_id><funding_grant_id>K24 HL137013</funding_grant_id><funding_grant_id>K23 HL133438</funding_grant_id><funding_grant_id>R21 EB027891</funding_grant_id><funding_grant_id>R01 HL125432</funding_grant_id><pubmed_authors>Krishnan JA</pubmed_authors><pubmed_authors>Bhakta NR</pubmed_authors><pubmed_authors>Hansel NN</pubmed_authors><pubmed_authors>Buhr RG</pubmed_authors><pubmed_authors>Fortis S</pubmed_authors><pubmed_authors>Barr RG</pubmed_authors><pubmed_authors>Dolezal B</pubmed_authors><pubmed_authors>O'Neal WK</pubmed_authors><pubmed_authors>Han MK</pubmed_authors><pubmed_authors>Drummond MB</pubmed_authors><pubmed_authors>Bhatt SP</pubmed_authors><pubmed_authors>Labaki WW</pubmed_authors><pubmed_authors>Paine R</pubmed_authors><pubmed_authors>Tashkin D</pubmed_authors><pubmed_authors>Kanner RE</pubmed_authors><pubmed_authors>Bowler RP</pubmed_authors><pubmed_authors>Criner G</pubmed_authors><pubmed_authors>Hoffman EA</pubmed_authors><pubmed_authors>Woodruff P</pubmed_authors><pubmed_authors>Comellas AP</pubmed_authors><pubmed_authors>Curtis JL</pubmed_authors><pubmed_authors>Cooper CB</pubmed_authors><pubmed_authors>Ronish B</pubmed_authors><pubmed_authors>Ortega VE</pubmed_authors><pubmed_authors>Hoesterey D</pubmed_authors><pubmed_authors>Kim V</pubmed_authors><pubmed_authors>Barjaktarevic I</pubmed_authors><pubmed_authors>Dransfield M</pubmed_authors><pubmed_authors>Couper D</pubmed_authors><pubmed_authors>Arjomandi M</pubmed_authors><pubmed_authors>Kaner RJ</pubmed_authors><pubmed_authors>Martinez F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ratio of FEV&lt;sub>1&lt;/sub>/Slow Vital Capacity of &lt; 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.</name><description>&lt;h4>Background&lt;/h4>Mild expiratory flow limitation may not be recognized using traditional spirometric criteria based on the ratio of FEV&lt;sub>1&lt;/sub>/FVC.&lt;h4>Research question&lt;/h4>Does slow vital capacity (SVC) instead of FVC increase the sensitivity of spirometry to identify patients with early or mild obstructive lung disease?&lt;h4>Study design and methods&lt;/h4>We included 854 current and former smokers from the Subpopulations and Intermediate Outcome Measures in COPD Study cohort with a postbronchodilator FEV&lt;sub>1&lt;/sub>/FVC ≥ 0.7 and FEV&lt;sub>1&lt;/sub> % predicted of ≥ 80% at enrollment. We compared baseline characteristics, chest CT scan features, exacerbations, and progression to COPD (postbronchodilator FEV&lt;sub>1&lt;/sub>/FVC, &lt; 0.7) during the follow-up period between 734 participants with </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jul</publication><modification>2025-05-29T20:04:46.483Z</modification><creation>2022-07-10T12:30:19.514Z</creation></dates><accession>S-EPMC8295909</accession><cross_references><pubmed>33539837</pubmed><doi>10.1016/j.chest.2021.01.067</doi></cross_references></HashMap>